TrademarkDir
EXPRESS SCRIPTS CLEARCARERX
LIVE

Serial Number

97876337

Owner

Express Scripts Strategic Development, Inc.

Attorney

Dennis S. Prahl

First Use Date

May 5, 2025

Filing Date

Apr 6, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EXPRESS SCRIPTS CLEARCARERX Trademark

Serial Number: 97876337

EXPRESS SCRIPTS CLEARCARERX is a trademark filed by Express Scripts Strategic Development, Inc. on April 6, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Express Scripts Strategic Development, Inc. (5 trademarks)

One Express Way
St. Louis, MO 63121

Entity Type: 03

Trademark Details

Filing Date

April 6, 2023

Registration Date

Not Registered

First Use Anywhere

May 5, 2025

First Use in Commerce

May 5, 2025

Published for Opposition

May 28, 2024

Goods & Services

Pharmacy benefit management services; pharmacy benefit management consulting services; advisory services and consultancy regarding pharmacy benefits; provision of information and analysis in the fields of pharmacy benefits; administration of pharmacy benefit plans; pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and providing a predictive model to determine patients' future prescription drug habits, all to identify potential cost savings and for clinical benefits; pharmacy benefit management services for organized labor

Drug utilization review services; pharmaceutical cost management services; strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior; market study and analysis of pharmacy benefits effecting health behavior change and choice at the patient level; providing information in the field of pharmaceutical cost management as provided to pharmacy benefit management services clients, consultants and brokers; cost management for the prescription drug plans of others; administration of a discount program for enabling members to obtain discounts on the purchase of drugs; business services, namely, prescription drug formulary cost management services; consulting services regarding pharmacy cost management

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2026 EXRA
STATEMENT OF USE PROCESSING COMPLETE
May 27, 2026 SUPC
SOU EXTENSION 3 GRANTED
May 27, 2026 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 26, 2026 AITU
USE AMENDMENT FILED
Jan 23, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 23, 2026 EISU
SOU TEAS EXTENSION RECEIVED
Jan 23, 2026 EEXT
SOU EXTENSION 3 FILED
Jan 22, 2026 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 17, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 16, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 16, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 24, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 23, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 23, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 2, 2024 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 23, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 19, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 19, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 19, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 19, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 19, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2023 NWOS
NEW APPLICATION ENTERED
Apr 10, 2023 NWAP

Related Trademarks

More from this Owner

EVERNORTH SIGNATURE

EVERNORTH SIGNATURE

EVERNORTH SIGNATURE PHARMACY BENEFIT SERVICES

EVERNORTH SIGNATURE PHARMACY BENEFIT SERVICES

SIGNATURE PHARMACY BENEFIT SERVICES

SIGNATURE PHARMACY BENEFIT SERVICES

EVERNORTH BENEFITS NAVIGATION

EVERNORTH BENEFITS NAVIGATION

EVERNORTH THERAPY LINK

EVERNORTH THERAPY LINK

ACCREDO SMART PATH

ACCREDO SMART PATH